UBS Maintains Buy on CryoPort, Raises Price Target to $28
Portfolio Pulse from richadhand@benzinga.com
UBS analyst John Sourbeer maintains a Buy rating on CryoPort (NASDAQ:CYRX) and raises the price target from $26 to $28.

June 06, 2023 | 1:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst John Sourbeer maintains a Buy rating on CryoPort and raises the price target from $26 to $28.
The UBS analyst's decision to maintain a Buy rating and raise the price target for CryoPort indicates a positive outlook for the company's stock. This news is likely to be perceived positively by investors, potentially leading to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100